Suppr超能文献

[提高穿刺活检中乳腺癌分级:使用Ki-67标记物进行分级]

[Improvement of breast cancer grading in punch biopsies: grading with the Ki-67 marker].

作者信息

von Wasielewski R, Klöpper K, Lück H J, Kreipe H

机构信息

Institut für Pathologie, Medizinische Hochschule, Carl-Neuberg Strasse 1, 30625, Hannover, Germany.

出版信息

Pathologe. 2006 Sep;27(5):337-45. doi: 10.1007/s00292-006-0855-9.

Abstract

The grading of invasive breast cancers according to Bloom and Richardson (Nottingham modification) provides one of the most important prognostic factors in addition to size and the status of the lymph nodes. Diagnostic reproducibility has been problematic in daily practice as the required criteria for selection and extent of the grading area are frequently not present in the punch biopsies.A total of 346 cases were retrospectively used to compare routine grading from surgical preparations with an equivalently small sample from punch biopsies. In addition, a modified grading of these small samples was developed with Ki-67 immunochemistry and the measurement of core size. In the case of modified grading, 1-3 points were given for Ki-67 and average maximum core diameter. Tubule development was evaluated with 1 or 2 points. A comparison for recurrence free survival and total survival showed significant prognostic differences between 3-5 points (low risk) and 6-8 points (high risk) in uni- and multivariate analyses. The evaluation criteria for Nottingham-Bloom-Richardson grading in a small tissue sample, such as that from a punch biopsy, can hardly be fulfilled. In our series, prognostic value was only found for nodal negative cases. After modification using objective parameters such as nuclear size measurement and Ki-67 proliferation index, a small tissue sample can prove to be of significant prognostic value for nodal negative as well as nodal positive cases.

摘要

根据布鲁姆和理查森(诺丁汉改良版)对浸润性乳腺癌进行分级,除了肿瘤大小和淋巴结状态外,这是最重要的预后因素之一。在日常实践中,诊断的可重复性存在问题,因为在穿刺活检中通常不存在分级区域选择和范围所需的标准。总共回顾性分析了346例病例,以比较手术标本的常规分级与穿刺活检中同样小样本的分级。此外,利用Ki-67免疫化学和核心大小测量,对这些小样本进行了改良分级。在改良分级中,根据Ki-67和平均最大核心直径给予1-3分。管状结构发育给予1或2分。单因素和多因素分析显示,在无复发生存率和总生存率方面比较,3-5分(低风险)和6-8分(高风险)之间存在显著的预后差异。在小组织样本(如穿刺活检样本)中,很难满足诺丁汉-布鲁姆-理查森分级的评估标准。在我们的系列研究中,仅在淋巴结阴性病例中发现了预后价值。使用核大小测量和Ki-67增殖指数等客观参数进行改良后,小组织样本对淋巴结阴性和阳性病例均具有显著的预后价值。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验